Veeva Systems修订了其2025年财政收入预测,导致股票价格下跌。 Veeva Systems revised its fiscal 2025 earnings forecast, leading to a drop in its stock price.

Veeva Systems是生命科学云基软件的提供者,它更新了其第25财政年度收入指南,预测EPS为6.44美元,收入为27.22-2.72.5亿美元。 Veeva Systems, a provider of cloud-based software for life sciences, updated its FY25 earnings guidance, projecting an EPS of $6.44 and revenue of $2.722-2.725 billion. 该公司的股本在星期四下跌6.08美元至231.66美元。 The company’s stock dropped $6.08 to $231.66 on Thursday. 分析师对Veeva的评级是“机动购买”,协商一致的目标价格为238.44美元。 Analysts have a "Moderate Buy" rating on Veeva, with a consensus target price of $238.44. Veeva为制药和生物技术部门的客户关系管理和数字资产管理提供了软件解决方案。 Veeva offers software solutions for CRM and digital asset management in pharmaceutical and biotech sectors.